Literature DB >> 16802381

B cell therapy with the anti-CD22 monoclonal antibody epratuzumab: comment on the editorial by St. Clair and Tedder.

David M Goldenberg, Rhona Stein, John P Leonard, Serge D Steinfeld, Thomas Dörner, Gerd R Burmester.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16802381     DOI： 10.1002/art.21937

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  2 in total

1.  Modulation of B cell regulatory molecules CD22 and CD72 in myasthenia gravis and multiple sclerosis.

Authors:  Jiayin Lu; Jing Li; Tai-qing Zhu; Longbo Zhang; Yuzhong Wang; Fa-fa Tian; Huan Yang
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

2.  Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus.

Authors:  Edmund A Rossi; Chien-Hsing Chang; David M Goldenberg
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.